Patients with high C-reactive protein (CRP) and high lipoprotein-associated phospholipase A2 (Lp-PLA2) levels have a significantly increased risk for coronary artery disease (CAD) death compared to those with high CRP and low Lp-PLA2 levels (p=0.048).

Authors

• Person: Not available Organization: National Lipid Association
  EBM Tools for Practice: Best Biomarkers for Inflammation

Sources

• EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org National Lipid Association via serper

Referenced by nodes (2)

• C-reactive protein concept
• coronary artery disease concept